Among these, SFN was isolated from broccoli in the early 1990s as an inducer of phase 2 enzymes (xenobiotic metabolism) and since then numerous studies have proposed various anti-neoplastic pharmacological aspects of SFN, thereby suggesting its potential as a promising candidate in cancer chemoprevention [15]. This evidence concerns the gene SFN and cancer.